Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Wells Fargo shifted ratings across its U.S. apparel and retail coverage, upgrading Victoria’s Secret and lowering its outlooks on Nike and Deckers. The bank’s analysts, led by Ike Boruchow, point to rapid uptake of GLP-1 weight-loss medications as a key demand driver that is reshaping consumer spending patterns in favor of clothing categories such …
Kratos Defense & Security Solutions has chosen Odon, Indiana as the location for its new mid-tier coupled arc jet and laser test facility under Project Helios. This facility aims to bridge the gap between laboratory material development and operational use for hypersonic systems, expanding the U.S. aerothermal testing infrastructure and supporting …
BioCardia announced FDA's agreement on two possible regulatory pathways for market clearance of its Helix Transendocardial Delivery Catheter System. The FDA showed no concerns regarding safety or device performance and prefers simultaneous approval with CardiAMP Cell Therapy. BioCardia aims to pursue both pathways to accelerate commercial opportuni…
Pacira BioSciences granted inducement awards, including stock options and restricted stock units, to ten new employees to incentivize employment under its Amended and Restated 2014 Inducement Plan. The awards were approved by the Board's People & Compensation Committee without stockholder approval. The grants include options exercisable at $24.69 p…
CCH Holdings Ltd, a Malaysian specialty hotpot restaurant chain, announced the effective implementation of its dual-class share structure on the Nasdaq Capital Market. The company's ordinary shares have been redesignated as Class A ordinary shares, with Class B shares carrying enhanced voting rights. Trading under the symbol CCHH will continue from…
Wrap Technologies, Inc. announced its participation in a major European law enforcement event in Italy to introduce its Non-Lethal Response ecosystem, including the BolaWrap device, immersive training platform WrapReality, and policy strategies. The company aims to expand adoption of its non-lethal public safety tools in Europe, highlighting operat…
Moomoo Canada, an affiliate of Nasdaq-listed Futu Holdings Limited, announces 'Canada's Top Trader,' the first live, real-money national trading competition in Canada. The competition runs from June 1-30, 2026, using real capital on the moomoo platform with a prize pool of approximately $1 million CAD. Educational resources and workshops are provid…
Alamar Biosciences announced nearly doubling its Q1 2026 revenue to $26 million driven by strong instrument placements and consumables sales. The company completed an IPO in April 2026 raising about $220 million net proceeds, strengthening its balance sheet to accelerate its Precision Proteomics platform adoption. Despite increased operating expens…
Humacyte, a Nasdaq-listed biotechnology company developing bioengineered human tissues, announces it will release its first quarter 2026 financial results and provide a corporate update via webcast and conference call on May 13, 2026. The company specializes in acellular tissue engineered vessels (ATEVs) with FDA approval in vascular trauma and ong…
MiMedx Group announces the commercial launch of G4Derm Plus, a novel flowable biomimetic matrix incorporating self-assembling peptide technology designed for complex wound management. The product has been cleared by the FDA and added to major group purchasing organization agreements (Premier and Vizient), enabling nationwide distribution to surgica…
Integra LifeSciences Holdings Corporation announced that its CFO, Lea Knight, will present at the BofA Securities 2026 Health Care Conference on May 12, 2026. The presentation will be webcast live on the company's investor relations website. The event highlights Integra LifeSciences' ongoing engagement with investors and its leadership position in …
ALX Oncology announced encouraging data from its Phase 1b/2 trial combining evorpacept and zanidatamab showing durable responses in HER2-positive metastatic breast cancer patients with high CD47 expression. The company is progressing well with its Phase 2 ASPEN-09-Breast trial targeting HER2-positive breast cancer with topline data expected mid-202…
V2X Inc. shares fell in premarket trading after Vertex Aerospace Holdco, managed by American Industrial Partners, sold roughly 2 million VVX shares in a $149 million secondary offering priced at $74.35 per share. The sale, arranged by Morgan Stanley, leaves an affiliated entity with a 1.2% stake in the company.
Jefferies reports that India’s cement industry is beginning to demonstrate capital discipline, with leading companies trimming or delaying expansion and cutting capital expenditure to prioritise higher capacity utilisation amid persistent supply-demand imbalances and regionally weak plant loadings. UltraTech’s strong cash generation supports a larg…
Sterling ticked up on Friday as market participants balanced renewed conflict in the Strait of Hormuz against rising political uncertainty in Britain. The pound's modest gain came despite a wider decline in market sentiment, with traders also focused on U.S. April payrolls and commentary from ING on binary outcomes for major currency pairs.
Rio Tinto is reviewing the economic prospects of the Los Azules copper deposit in Argentina and is considering raising its current 17.2% interest. The assessment is being carried out by Rio’s technical team alongside tests of Nuton LLC’s leaching process, while McEwen Copper and other investors press ahead with financing plans for the large-scale p…
DeepSeek is seeking up to 50 billion yuan ($7.35 billion) in its inaugural funding round, with founder Liang Wenfeng expected to supply the largest portion. The effort has prompted the AI lab to hasten steps toward revenue generation and to plan more frequent model updates, including a V4 update slated for June. If completed, the round would repres…
3 E Network Technology Group Limited announced a $1.3 million convertible note financing aimed at advancing its semiconductor and AI infrastructure development. The company officially established its Chip Business Unit to develop proprietary core storage chips, acquire critical IP and design tools, and secure manufacturing capacity. This strategic …
Global equities rose to new highs this week on hopes for a U.S.-Iran peace deal, but Barclays strategist Emmanuel Cau cautions that a durable, broader market rally requires both reopening of the Strait of Hormuz and participation beyond the stretched semiconductors trade. Barclays points to liquidity support, strong first-quarter earnings driven by…
Federal Reserve Governor Stephen Miran said he hopes that Jerome Powell’s continued service on the Fed’s board after his chairmanship concludes will be limited to a clear transition period. Miran, speaking on Fox Business Network’s 'Mornings with Maria', emphasized the need to avoid divided loyalties and uncertainty about who is in charge. Powell h…
Qualcomm Inc. stock jumped about 6% Friday morning following an upgrade from Daiwa Securities analyst Louis Miscioscia, who moved the chipmaker from Neutral to Outperform and set a $225 price target. The firm highlighted longer-term revenue growth opportunities tied to data center CPUs, physical computing and edge AI even as Qualcomm’s fiscal third…
Barclays analysts said they expect Home Depot and Lowe's to report first-quarter results a bit above consensus, citing stabilizing demand, easier year-over-year comparisons and attractive valuations. The firm warned that progress on interest rates and housing activity has been slower than anticipated, but its company and supplier trackers show Q1 t…
Zeta Global ($17.31) combines strong top-line growth and growing free cash flow with modest leverage and a valuation that looks like adtech, not SaaS. We favor a long trade into strength with a $24.90 target and a $14.00 stop, horizon 180 trading days.
Plus Therapeutics announced that key clinical and translational data from their Phase 1 ReSPECT-LM trial of REYOBIQ were presented at the 2026 American Association of Neurological Surgeons meeting. The data demonstrated encouraging survival outcomes, favorable safety profiles, and potential immune-modulatory effects in treating leptomeningeal metas…
Traws Pharma, a clinical-stage biopharmaceutical company listed on NASDAQ, announced plans to advance clinical candidates targeting hantavirus infections, which currently have no approved treatments and carry a high fatality rate. Building on its expertise in antiviral drugs for negative-strand RNA viruses, Traws aims to rapidly identify and develo…
